{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T22:23:39Z","timestamp":1787783019227,"version":"build-2784847793"},"reference-count":34,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81872524"],"award-info":[{"award-number":["81872524"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82073431"],"award-info":[{"award-number":["82073431"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2022M723613"],"award-info":[{"award-number":["2022M723613"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jdsjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Dermatological Science"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.jdermsci.2023.05.001","type":"journal-article","created":{"date-parts":[[2023,5,4]],"date-time":"2023-05-04T11:59:18Z","timestamp":1683201558000},"page":"89-98","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Topical histone deacetylase 1 inhibitor Entinostat ameliorates psoriasiform dermatitis through suppression of IL-17A response"],"prefix":"10.1016","volume":"110","author":[{"given":"Yanyun","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyao","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhsien","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liangchun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jdermsci.2023.05.001_bib1","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1146\/annurev-immunol-032713-120225","article-title":"Immunology of psoriasis","volume":"32","author":"Lowes","year":"2014","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.jdermsci.2023.05.001_bib2","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.3389\/fimmu.2018.01549","article-title":"The interplay between keratinocytes and immune cells in the pathogenesis of psoriasis","volume":"9","author":"Albanesi","year":"2018","journal-title":"Front Immunol."},{"issue":"1","key":"10.1016\/j.jdermsci.2023.05.001_bib3","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/prd.12083","article-title":"Basic biology and role of interleukin-17 in immunity and inflammation","volume":"69","author":"Zenobia","year":"2015","journal-title":"Periodontol"},{"key":"10.1016\/j.jdermsci.2023.05.001_bib4","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.3389\/fimmu.2018.01682","article-title":"The IL-17 family of cytokines in Psoriasis: IL-17A and beyond","volume":"9","author":"Brembilla","year":"2018","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.jdermsci.2023.05.001_bib5","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21041275","article-title":"Interleukin-17A and Keratinocytes in Psoriasis","volume":"21","author":"Furue","year":"2020","journal-title":"Int J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.jdermsci.2023.05.001_bib6","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1056\/NEJMoa1314258","article-title":"Secukinumab in plaque psoriasis--results of two phase 3 trials","volume":"371","author":"Langley","year":"2014","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.jdermsci.2023.05.001_bib7","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1056\/NEJMoa1512711","article-title":"Phase 3 trials of ixekizumab in moderate-to-severe plaque psoriasis","volume":"375","author":"Gordon","year":"2016","journal-title":"N. Engl. J. Med"},{"issue":"2","key":"10.1016\/j.jdermsci.2023.05.001_bib8","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1111\/bjd.17689","article-title":"Localization of treatment-resistant areas in patients with psoriasis on biologics","volume":"181","author":"Hjuler","year":"2019","journal-title":"Br. J. Dermatol."},{"issue":"8","key":"10.1016\/j.jdermsci.2023.05.001_bib9","first-page":"845","article-title":"Open-Label study evaluating adjunctive calcipotriene 0.005%\/Betamethasone dipropionate 0.064% foam in psoriasis patients with inadequate response to biologic therapy","volume":"17","author":"Bagel","year":"2018","journal-title":"J. Drugs Dermatol."},{"issue":"1","key":"10.1016\/j.jdermsci.2023.05.001_bib10","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s40257-021-00649-w","article-title":"New topical therapies for psoriasis","volume":"23","author":"L\u00e9","year":"2022","journal-title":"Am. J. Clin. Dermatol."},{"issue":"6649","key":"10.1016\/j.jdermsci.2023.05.001_bib11","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/38664","article-title":"Histone acetylation in chromatin structure and transcription","volume":"389","author":"Grunstein","year":"1997","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.jdermsci.2023.05.001_bib12","doi-asserted-by":"crossref","DOI":"10.3390\/life10090157","article-title":"Histone Deacetylase 1 and Sirtuin 1 expression in psoriatic skin: a comparison between guttate and plaque psoriasis","volume":"10","author":"Hwang","year":"2020","journal-title":"Life"},{"issue":"4","key":"10.1016\/j.jdermsci.2023.05.001_bib13","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1684\/ejd.2011.1383","article-title":"Abnormal histone modifications in PBMCs from patients with psoriasis vulgaris","volume":"21","author":"Zhang","year":"2011","journal-title":"Eur. J. Dermatol."},{"key":"10.1016\/j.jdermsci.2023.05.001_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.leukres.2021.106707","article-title":"Phase 1 study of the histone deacetylase inhibitor Entinostat plus clofarabine for poor-risk Philadelphia chromosome-negative (newly diagnosed older adults or adults with relapsed refractory disease) acute lymphoblastic leukemia or biphenotypic leukemia","volume":"110","author":"Carraway","year":"2021","journal-title":"Leuk. Res"},{"issue":"1","key":"10.1016\/j.jdermsci.2023.05.001_bib15","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1186\/s12885-021-08973-4","article-title":"Phase 1 trial of Entinostat as monotherapy and combined with exemestane in Japanese patients with hormone receptor-positive advanced breast cancer","volume":"21","author":"Masuda","year":"2021","journal-title":"BMC Cancer"},{"key":"10.1016\/j.jdermsci.2023.05.001_bib16","doi-asserted-by":"crossref","first-page":"D991","DOI":"10.1093\/nar\/gks1193","article-title":"NCBI GEO: archive for functional genomics data sets--update","volume":"41","author":"Barrett","year":"2013","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jdermsci.2023.05.001_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.jid.2021.03.019","article-title":"IRAK2 has a critical role in promoting feed-forward amplification of epidermal inflammatory responses","author":"Shao","year":"2021","journal-title":"J. Investig. Dermatol."},{"issue":"5","key":"10.1016\/j.jdermsci.2023.05.001_bib18","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1016\/j.jid.2021.10.027","article-title":"Bile acids improve psoriasiform dermatitis through inhibition of IL-17A expression and CCL20-CCR6-Mediated trafficking of T cells","volume":"142","author":"Shi","year":"2022","journal-title":"J. Invest Dermatol."},{"issue":"9","key":"10.1016\/j.jdermsci.2023.05.001_bib19","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1016\/j.jid.2020.01.020","article-title":"Short-Term exposure to a western diet induces psoriasiform dermatitis by promoting accumulation of IL-17A-Producing \u03b3\u03b4 T cells","volume":"140","author":"Shi","year":"2020","journal-title":"J. Invest Dermatol."},{"key":"10.1016\/j.jdermsci.2023.05.001_bib20","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.714274","article-title":"ULK1 inhibition as a targeted therapeutic strategy for psoriasis by regulating keratinocytes and their crosstalk with neutrophils","volume":"12","author":"Qiu","year":"2021","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.jdermsci.2023.05.001_bib21","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.immuni.2011.08.001","article-title":"Pivotal role of dermal IL-17-producing \u03b3\u03b4 T cells in skin inflammation","volume":"35","author":"Cai","year":"2011","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.jdermsci.2023.05.001_bib22","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/jid.2012.260","article-title":"CCR6 is required for epidermal trafficking of \u03b3\u03b4-T cells in an IL-23-induced model of psoriasiform dermatitis","volume":"133","author":"Mabuchi","year":"2013","journal-title":"J. Investig. Dermatol."},{"issue":"6","key":"10.1016\/j.jdermsci.2023.05.001_bib23","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1172\/JCI61862","article-title":"Ror\u03b3t+ innate lymphocytes and \u03b3\u03b4 T cells initiate psoriasiform plaque formation in mice","volume":"122","author":"Pantelyushin","year":"2012","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.jdermsci.2023.05.001_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2019.102379","article-title":"Histone deacetylase 1 (HDAC1): A key player of T cell-mediated arthritis","volume":"108","author":"G\u00f6schl","year":"2020","journal-title":"J. Autoimmun."},{"issue":"7","key":"10.1016\/j.jdermsci.2023.05.001_bib25","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1038\/jid.2014.98","article-title":"IL-23 from Langerhans cells is required for the development of imiquimod-induced psoriasis-like dermatitis by induction of IL-17A-producing \u03b3\u03b4 T cells","volume":"134","author":"Yoshiki","year":"2014","journal-title":"J. Invest Dermatol."},{"issue":"2","key":"10.1016\/j.jdermsci.2023.05.001_bib26","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.immuni.2009.08.001","article-title":"Interleukin-1 and IL-23 induce innate IL-17 production from gammadelta T cells, amplifying Th17 responses and autoimmunity","volume":"31","author":"Sutton","year":"2009","journal-title":"Immunity"},{"issue":"10","key":"10.1016\/j.jdermsci.2023.05.001_bib27","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/s41577-018-0037-z","article-title":"Histone deacetylase function in CD4(+) T cells","volume":"18","author":"Ellmeier","year":"2018","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jdermsci.2023.05.001_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/bs.ai.2020.06.001","article-title":"Histone deacetylases as targets in autoimmune and autoinflammatory diseases","volume":"147","author":"Hamminger","year":"2020","journal-title":"Adv. Immunol."},{"issue":"1","key":"10.1016\/j.jdermsci.2023.05.001_bib29","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1002\/jcb.29137","article-title":"Histone deacetylases 1 and 2 inhibition suppresses cytokine production and osteoclast bone resorption in vitro","volume":"121","author":"Algate","year":"2020","journal-title":"J. Cell Biochem"},{"issue":"9","key":"10.1016\/j.jdermsci.2023.05.001_bib30","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1093\/ibd\/izy182","article-title":"Faecalibacterium prausnitzii Produces Butyrate to Maintain Th17\/Treg balance and to ameliorate colorectal colitis by inhibiting histone deacetylase 1","volume":"24","author":"Zhou","year":"2018","journal-title":"Inflamm. Bowel Dis."},{"issue":"8","key":"10.1016\/j.jdermsci.2023.05.001_bib31","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1111\/exd.14332","article-title":"Dysregulated epigenetic modifications in psoriasis","volume":"30","author":"Zeng","year":"2021","journal-title":"Exp. Dermatol."},{"issue":"2","key":"10.1016\/j.jdermsci.2023.05.001_bib32","doi-asserted-by":"crossref","first-page":"190","DOI":"10.5021\/ad.2021.33.2.190","article-title":"Topical application of MS-275 decreases the imiquimod-induced hyperproliferative epidermis and Interleukin-23 expression in the upper Dermis of BALB\/c mouse","volume":"33","author":"Friedland","year":"2021","journal-title":"Ann. Dermatol."},{"issue":"4","key":"10.1016\/j.jdermsci.2023.05.001_bib33","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1111\/exd.14502","article-title":"Vorinostat, a histone deacetylase inhibitor, as a potential novel treatment for psoriasis","volume":"31","author":"Samuelov","year":"2022","journal-title":"Exp. Dermatol."},{"issue":"5","key":"10.1016\/j.jdermsci.2023.05.001_bib34","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1084\/jem.20132378","article-title":"SIRT1 deacetylates ROR\u03b3t and enhances Th17 cell generation","volume":"212","author":"Lim","year":"2015","journal-title":"J. Exp. Med."}],"container-title":["Journal of Dermatological Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923181123001172?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923181123001172?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T04:52:59Z","timestamp":1760331179000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923181123001172"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["S0923181123001172"],"URL":"https:\/\/doi.org\/10.1016\/j.jdermsci.2023.05.001","relation":{},"ISSN":["0923-1811"],"issn-type":[{"value":"0923-1811","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Topical histone deacetylase 1 inhibitor Entinostat ameliorates psoriasiform dermatitis through suppression of IL-17A response","name":"articletitle","label":"Article Title"},{"value":"Journal of Dermatological Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdermsci.2023.05.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Japanese Society for Investigative Dermatology. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}